Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where procedure alternatives remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/moomoos-futu-reports-revenue-growth-of-86-8-yoy-in-q4-2024/